Virtual Reality in Assisted Psychedelia

Virtual Reality and Psychedelic Therapy: A New frontier in Psychotherapy. What are the advances?

Anonymous young guy testing new VR goggles

VR is quickly becoming a part of our lives that we can’t live without. It’s been used for gaming and as an educational tool or therapy provider. Now there’s research about how it could be helpful when treating psychiatric conditions such as depression–a recent paper published by academics Agnieszka Sekula & Dr. Prash Puspanathan outlined their ideas on incorporating virtual worlds into aspects throughout the process.

What Is Psychotherapy?

In recent years, there has been significant interest in using psychedelic substances for psychotherapy. The most prominent example is psilocybin, which has shown promise as a treatment against post-traumatic stress disorder (PTSD), anxiety, and addiction porno français. More research is needed on its effectiveness before you can draw firm conclusions. Another instance where these medications might come into play is during therapy sessions themselves; some patients have found that they can heal from past trauma by undergoing “mystical” experiences while under milder doses than would otherwise produce consciousness changes.

Enhancing Psychedelic Therapy Through Technology

Free stock photo of appartment, at home, beautiful home

The use of virtual and augmented reality technology is growing in popularity for mental health treatments. Tripp has raised US$15million to create VR applications that can assist people with alternative states or thoughts while recently acquiring PsyAssist, which specializes in making best practice protocols for psychedelic-assisted therapy.

The guidelines provide a way for patients to self-administer psychedelic compounds without relying on psychotherapists. That would overcome one of the biggest obstacles faced in drug development, reducing reliance on psychotherapists and, consequently, resources required for these therapies. It reduces the resource requirements in therapy settings that rely heavily upon these specialist professionals with extensive training relevant specifically to their field’s needs. For instance, psilocybin-assisted treatments are done clinically or at home via an internet connection. The connection happens through mobile devices like laptops, which connect wirelessly rather than requiring cords across rooms.

With the cost of treatments being reduced, more people will be approved by insurers and regulators, which supports our industry’s ability to reach $100 billion in size. As a result, drug developers are aligning themselves with technology start-ups that help bring about enhanced patient outcomes through virtual or augmented reality opportunities.

Mental health is a severe issue that affects many people. What better way to help those who need it than with an interactive experience? Through their VR headset company, Tripp has been able to provide this for patients by creating immersive worlds where they can escape from reality or have fun exploring new places.

VR technology to help patients with personalized treatments for mental health indicators such as PTSD, anxiety, and depression has been around since the creation of digital tools to alleviate these conditions. Tryptamines have also shown positive effects on those same disorders by providing an escape route from one’s current reality into new mindsets that are similar aesthetically speaking. Users can’t tell whether they’re being transported back or forth between dimensions while exploring the virtual world!

The PSYCH investor summit will be a must-attend for anyone interested in psychedelic technology this October. The event features presentations from industry leaders and researchers. The leaders are shaping what’s subsequent within this rapidly evolving sector of our economy. The economy has been receiving increased attention as we move closer toward the 2020 elections, with candidates discussing issues critical to everyone, including retirement plans (or lack thereof).